Literature DB >> 24006056

Analyzing Myc in cell transformation and evolution.

Markus Hartl1, Klaus Bister.   

Abstract

The myc oncogene was originally identified as a transduced allele (v-myc) in the genome of a highly oncogenic avian retrovirus. The protein product (Myc) of the cellular c-myc proto-oncogene represents the key component of a transcription factor network controlling the expression of a large fraction of all human genes. Myc regulates fundamental cellular processes like growth, metabolism, proliferation, differentiation, and apoptosis. Mutational deregulation of c-myc leading to increased levels of the Myc protein is a frequent event in the etiology of human cancers. In this chapter, we describe cell systems and experimental strategies to monitor and quantify the oncogenic potential of myc alleles and to isolate and characterize transcriptional targets of Myc that are relevant for the cell transformation process. We also describe experimental procedures to study the evolutionary origin of myc and to analyze structure and function of the ancestral myc proto-oncogenes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006056      PMCID: PMC5330430          DOI: 10.1007/978-1-62703-429-6_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

Review 1.  Deconstructing myc.

Authors:  R N Eisenman
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

3.  The RNA of avian acute leukemia virus MC29.

Authors:  P H Duesberg; K Bister; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  CnNK-2, an NK-2 homeobox gene, has a role in patterning the basal end of the axis in hydra.

Authors:  A Grens; L Gee; D A Fisher; H R Bode
Journal:  Dev Biol       Date:  1996-12-15       Impact factor: 3.582

Review 6.  Oncogenes in retroviruses and cells: biochemistry and molecular genetics.

Authors:  K Bister; H W Jansen
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

7.  Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra.

Authors:  Markus Hartl; Anna-Maria Mitterstiller; Taras Valovka; Kathrin Breuker; Bert Hobmayer; Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

Review 8.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

9.  Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1).

Authors:  Markus Hartl; Andrea Nist; M Imran Khan; Taras Valovka; Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

10.  Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network.

Authors:  Amir Orian; Bas van Steensel; Jeffrey Delrow; Harmen J Bussemaker; Ling Li; Tomoyuki Sawado; Eleanor Williams; Lenora W M Loo; Shaun M Cowley; Cynthia Yost; Sarah Pierce; Bruce A Edgar; Susan M Parkhurst; Robert N Eisenman
Journal:  Genes Dev       Date:  2003-04-14       Impact factor: 11.361

View more
  2 in total

1.  K9(C4H4FN2O2)2Nd(PW11O39)2·25H2O induces apoptosis in human lung cancer A549 cells.

Authors:  Rong-Yao Xia; Ran-Ran Zhang; Zhe Jiang; Ya-Jiao Sun; Jing Liu; Fu-Hui Chen
Journal:  Oncol Lett       Date:  2016-12-28       Impact factor: 2.967

2.  Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms.

Authors:  Zhaohui Liu; Ying Tong; Yuanlin Liu; Huaping Liu; Chundong Li; Yue Zhao; Yi Zhang
Journal:  Cancer Cell Int       Date:  2014-11-26       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.